Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea L Kasinski

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Oncotarget|November 1, 2019
Combatting PDAC with two tumor-targeting small RNAsAndrea L Kasinski
Frontiers in Genetics|September 6, 2023
Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and diseaseAlejandra Agredo, Andrea L Kasinski
Trends in Cancer|August 24, 2020
InVivo Cancer-Based Functional GenomicsChennan Li, Andrea L Kasinski
DNA and Cell Biology|October 11, 2012
Understanding the epigenetic interface between the cell and the genome: a supplemental issue of DNA and cell biology on epigeneticsAndrea L Kasinski, Zachary Pincus
Journal of Visualized Experiments : Jove|October 23, 2023
Tracking miRNA Release into Extracellular Vesicles using Flow CytometryHumna Hasan, Andrea L Kasinski
Epigenetics|October 18, 2025
Insight into the mechanisms and dysregulation of KMT5C-H4K20me3 in cancerJihye Son, Andrea L Kasinski
Cancers|July 31, 2015
MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to TherapyEsteban A Orellana, Andrea L Kasinski
Frontiers in Oncology|July 3, 2023
Emerging diversity in extracellular vesicles and their roles in cancerIkjot S Sohal, Andrea L Kasinski
Nature Reviews. Cancer|November 25, 2011
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapyAndrea L Kasinski, Frank J Slack
Cancer Research|September 12, 2012
miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinomaAndrea L Kasinski, Frank J Slack
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Oncotarget|November 1, 2019
Combatting PDAC with two tumor-targeting small RNAsAndrea L Kasinski
Frontiers in Genetics|September 6, 2023
Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and diseaseAlejandra Agredo, Andrea L Kasinski
Trends in Cancer|August 24, 2020
InVivo Cancer-Based Functional GenomicsChennan Li, Andrea L Kasinski
DNA and Cell Biology|October 11, 2012
Understanding the epigenetic interface between the cell and the genome: a supplemental issue of DNA and cell biology on epigeneticsAndrea L Kasinski, Zachary Pincus
Journal of Visualized Experiments : Jove|October 23, 2023
Tracking miRNA Release into Extracellular Vesicles using Flow CytometryHumna Hasan, Andrea L Kasinski
Epigenetics|October 18, 2025
Insight into the mechanisms and dysregulation of KMT5C-H4K20me3 in cancerJihye Son, Andrea L Kasinski
Cancers|July 31, 2015
MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to TherapyEsteban A Orellana, Andrea L Kasinski
Frontiers in Oncology|July 3, 2023
Emerging diversity in extracellular vesicles and their roles in cancerIkjot S Sohal, Andrea L Kasinski
Nature Reviews. Cancer|November 25, 2011
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapyAndrea L Kasinski, Frank J Slack
Cancer Research|September 12, 2012
miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinomaAndrea L Kasinski, Frank J Slack
Pageof 5